XXII
Companies
NASDAQ
22nd Century Group Inc.
Consumer Staples
$10.12
+$4.81 (+90.63%)
Price Chart
Overview
About XXII
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Market Cap
$6.3M
Volume
1.8M
Avg. Volume
1.1M
P/E Ratio
-0.06880733
Dividend Yield
0.00%
Employees
61.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.50
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
High Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, XXII shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$6.3M
Volume1.8M
P/E Ratio-0.07
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 20, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025